KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,130,522 | +38.8% | 3,440,345 | +29.8% | 4.68% | +33.1% |
| Q2 2023 | $23,862,537 | +14.5% | 2,651,393 | 0.0% | 3.51% | +13.1% |
| Q1 2023 | $20,839,949 | -3.6% | 2,651,393 | -17.1% | 3.10% | -1.1% |
| Q4 2022 | $21,607,975 | -17.3% | 3,196,446 | +77.6% | 3.14% | -2.0% |
| Q3 2022 | $26,118,000 | +47.5% | 1,800,000 | 0.0% | 3.20% | +19.2% |
| Q2 2022 | $17,712,000 | +85.4% | 1,800,000 | +177.7% | 2.69% | +40.7% |
| Q1 2022 | $9,555,000 | – | 648,269 | – | 1.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |